Crossmark

Identification and treatment of myeloma cast nephropathy with crystalline light chain proximal tubulopathy induced by Vλ2 light chain

Crossref DOI link: https://doi.org/10.1007/s40620-024-02156-7

Published Online: 2024-12-17

Published Print: 2025-01-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Wang, Xin

Yu, Xiao-juan

Wang, Shuang

Wang, Su-xia

Zhou, Fu-de

Zhao, Ming-hui
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (82070747)

National Natural Science Foundation of China (82170724)

National Natural Science Foundation of China (82070747)

National Natural Science Foundation of China (82170724)
License Information

Version of Record valid from 2024-12-17

Text and Data Mining valid from 2024-12-17

Version of Record valid from 2024-12-17
More Information

Article History

Received: 17 April 2024

Accepted: 5 November 2024

First Online: 17 December 2024

Declarations

:

: The authors declare that they have no conflicts of interest.

: The study involving a human participant was reviewed and approved by the Ethics Committee of the Peking University First Hospital (approval number: 2020[012]). All procedures followed the ethical standards of the Peking University First Hospital Human Research Ethics Committee and the Helsinki Declaration.

: Written informed consent was obtained from the patient for publication of the research letter and any accompanying images.